Table 1.
Characteristics of the 11 704 subjects in relation to DBP phenotypes.
Table 2.
Body height, serum calcium, hip circumference, and serum 25(OH)D in relation to homozygote phenotypes in the females and males.
Table 3.
Number of incident endpoints (MI, T2DM, total cancer and death and types of cancer) after Tromsø 4 in 1994 (those with their first endpoint before Tromsø 4 excluded) in relation to DBP phenotype.
Table 4.
Gender adjusted Cox hazard ratios and 95% confidence intervals for incident cancer (all locations) according to DBP phenotype groups.